Hiba F Muddather

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Emergency medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
DPP-4 Inhibitors in Female Cancers: Opportunities for Drug Repurposing.

|Oct 29, 2025
In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Atorvastatin: A Focus on Cervical and Head and Neck Cancers.

Hiba F Muddather, Noémi Bózsity, György T Balogh

|Jul 27, 2024
Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines.

Nikoletta Szemerédi, Zsuzsanna Schelz, Dária Antónia Horvath

|Jul 26, 2024
An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer.

Zsuzsanna Schelz, Hiba F Muddather, Fatemeh Sheihaki Jaski

|Sep 28, 2023
Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance.

Zsuzsanna Schelz, Hiba F Muddather, István Zupkó

|Apr 18, 2022
Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan.

Kannan O Ahmed, Ashraf M Ahmed, Mojahed B Wali

Pageof 2

Frequent Collaborators

5 joint publications

Zsuzsanna Schelz

5 joint publications

István Zupkó

3 joint publications

Noémi Bózsity

1 joint publications

Moawia M A Elhassan